Elevated serum PD-L1 has recently been identified as a poor prognostic factor in several cancer types, including multiple myeloma gastric cancer, thyroid gland carcinoma, non-small cell lung cancer (NSCLC), breast cancer, and soft tissue sarcomas [34,35,36,37,38,39,40]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.